baber/WOPTO huggingface dataset:
Patent NZ-502642-A (NZ)
Title: Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
Inventor: BECK JAMES P
IPC: A61P25/22
Filed: 1998-07-02
Abstract: Compounds of formula I wherein: A is N or C-R7; B is N or C-R8; provided that at least one of the groups A and B is N; D is an aryl or heteroaryl group attached through an unsaturated carbon atom; X is selected from the group CH-R9, N-R10, O, S(O)n and a bond; n is 0, 1 or 2; R1 is selected from the group C1-C10 alkyl, C2-C10 alkenyl, C2-10 alkynyl, C3-8 cycloalkyl, C3-6 cycloalkyl-C1-6alkyl, C1-4 alkoxy-C1-4 alkyl, -SO2-C1-10 alkyl,-SO2-R1a, and -SO2-R1b; R1 is substituted with 0-1 substituents selected from the group -CN, -S(O)nR14b, -COR13a, -CO2R13a, -NR15aCOR13a,-N(COR13a)2, -NR15aCONR13aR16a, -NR15aCO2R14b,-CONR13aR16a, 1-morpholinyl, 1-piperidinyl,1-piperazinyl, and C3-8 cycloalkyl, wherein 0-1 carbon atoms in the C4-8 cycloalkyl is replaced by a group selected from the group -0-, -S(O)n-, -NR13a-, -NCO2R14b-, -NCOR14b- and NSO2R14b -, and wherein N4 in 1-piperazinyl is substituted with 0-1 substituents selected from the group R13a, CO2R14b, COR14b and SO2R14b; R1 is also substituted with 0-3 substituents independently selected at each occurrence from the group R1a, R1b, R1c, C1-6 alkyl, C2-8 alkenyl, C2-8 alkynyl, Br, Cl, F, I, C1-4 haloalkyl, -OR13a, -NR13aR16a, C1-4 alkoxy-C1-4alkyl, and C3-8 cycloalkyl which is substituted with 0-1 R9 and in which 0-1 carbons of C4-8 cycloalkyl is replaced by -O-; provided that R1 is other than: (a) a cyclohexyl-(CH2)2- group; (b) a 3-cyclopropyl-3-methoxypropyl group; (c) an unsubstituted-(alkoxy)methyl group; and (d) a 1-hydroxyalkyl group; also provided that when R1 alkyl substituted with OH, then the carbon adjacent to the ring N is other than CH2. Corticotropin releasing factor (CRF) antagonists of formula (I) and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress disorder, supranuclear palsy and feeding disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress in mammals.
Patent NZ-502658-A (NZ)
Title: Fluoropyrazole-biphenylamide fungicides and a method for controlling harmful fungi
Inventor: EICKEN KARL
IPC: C07D231/16
Filed: 1998-07-25
Abstract: The biphenyl amide of the formula (I) and salts thereof, where the radicals R1, R2 and R3 have the following meanings: R1 is H or F R2 is H, halogen, C1-C4-alkyl, halomethyl, C1-C4-alkoxy or C1-C4-alkylthio R3 is methyl, difluoromethyl or trifluoromethyl Also described is a composition for controlling harmful fungi, comprising an effective amount of at least one compound of formula I. Also described is a method for controlling harmful fungi, comprising treating the harmful fungi, their habitat or the plants, spaces, areas or materials to be kept free from them with an effective amount of at least one compound of the formula (I) or a salt thereof. Also described is the use of the compound of formula (I) or a salt thereof or the use of the composition (described above) for controlling harmful fungi.
Patent NZ-504163-A (NZ)
Title: A pharmaceutical collocation comprising a PDE5 inhibitor, a package and a label
Inventor: EMMICK JEFFREY THOMAS
IPC: A61K31/00
Filed: 2000-04-26
Abstract: A pharmaceutical article for use in patients suffering from sexual dysfunction.  The article comprises: (a) an oral dosage form comprising about 1 to about 20 mg of a selective PDE5 inhibitor having at least a 100 fold differential in IC50 values for the inhibition of PDE5 versus PDE6, at least 1000 fold differential in IC50 values for the inhibition of PDE5 versus PDE1c, an IC50 less than 10nm, and a sufficient bioavailability to be effective in about 1 to about 20 mg unit oral dosages; (b) a package insert providing that the PDE5 inhibitor is useful to treat sexual dysfunction in a patient in need thereof and that is free of any contraindications regarding administration of the PDE5 inhibitor to a patient suffering from a retinal disease; and combinations thereof; and (c) a container.
Patent NZ-509864-A (NZ)
Title: Synthetic mutants of the p53 gene and uses thereof
Inventor: YUEN KAI FUNG
IPC: C07K14/47
Filed: 1994-09-01
Abstract: A synthetic mutated p53 gene that encodes a mutated functionally active p53 protein is described.  The mutated p53 gene is mutated by changing the nucleotide sequence encoding the amino acids in conserved homology regions of the p53 protein selected from the group consisting of P1, P3 and P5. Also described is the therapeutic use of the mutated p53 gene for treating non-cancerous proliferating cell disease, for example, psoriasis, ichthyosis, pailloma, basal cell carcinoma, squamous cell carcinoma, fibroproliferative diseases, vasoproliferative diseases and dermaproliferative diseases.
Patent NZ-510320-A (NZ)
Title: Ground and rock anchoring utilising helical flight hollow screw-in anchor with grout extending beyond anchor, typically with reinforcing tie
Inventor: ANDERSON DALE
IPC: E02D5/80
Filed: 2001-03-05
Abstract: An in situ ground anchor comprising an opened ended hollow shaft equipped with an exterior helical flight for screwing the shaft into the soil layer, a column of hardened grout cast within the anchor and extending beyond the leading end of the anchor into a rock layer and a tie extending through the anchor and into the column extending beyond the anchor.
Patent NZ-511441-A (NZ)
Title: Remote reformulation and testing results for chemical products
Inventor: SCHULLER JOAN A
IPC: G06Q30/02
Filed: 2001-05-01
Abstract: Client computers 111, 112, 113 can query a server computer 120 with a chemical product identifier, and in response to such queries the server computer can schedule the testing of a sample of an identified product and store the test results in a database 125. In response to a subsequent query from a user the stored results may be provided to a user over a network.  In another embodiment the server receives input data identifying a formulation of a chemical product from a client computer, retrieves data associated with the formulation from the database, and processes the data to determine characteristics associated with the chemical produced in accordance with the formulation.  The user at the client computer interacts with the server to determine a modification of the formulation, and the data associated with the modified formulation is processed to determine the characteristics associated with the modified formulation, which is then presented to the user.
Patent NZ-512386-A (NZ)
Title: Extended polymethylene poly(phenylisocyanate) resin binders for the production of wood composite products
Inventor: ROSTHAUSER JAMES W
IPC: B29K105/16
Filed: 1999-12-10
Abstract: The disclosed relates to a process for the production of wood composite materials. This process comprises combining wood particles with a mixture comprising a solid compound comprising urea and/or melamine, and a polymethylene poly(phenyl isocyanate), followed by molding or compressing the coated combination of wood particles.
Patent NZ-516832-A (NZ)
Title: Load cell with galvanic corrosion suppression between strain body and member attached to strain body
Inventor: CHIMURA YUKIKO
IPC: G01G3/14
Filed: 2001-05-30
Abstract: A load cell 1 includes a strain body 2, a bridge circuit and a coating film.  The bridge circuit comprises a strain gauge 7 arranged on the strain body 2. The coating film is formed on the strain body 2 and covers at least a portion of the strain body 2 attached to a member made of a metal-material dissimilar to the strain body and a strain occurring portion of the strain body 2 except for a portion to be attached to the strain gauge 7, includes a coating layer made of resin having a glass transition temperature of 40°C or more, and has an electrical insulating property.
Patent NZ-523804-A (NZ)
Title: Peroxisome proliferator activated receptor agonists
Inventor: BROOKS DAWN ALISA
IPC: A61P9/12
Filed: 2001-08-23
Abstract: A compound of formula (I), wherein: R1 is an optionally substituted aryl, heteroaryl, cycloalkyl, heterocyclo-alkyl, aryl-alkyl, heteroaryl-alkyl, cycloalkyl-alkyl, or t-butyl, R2 is H, alkyl, haloalkyl or phenyl, n is 2, 3 or 4 W is CH2, CH(OH), C(O) or O, Y is optionally substituted thiophen-2,5-diyl or phenylene, R3 is alkyl or haloalkyl, R4 is optionally substituted phenyl, naphthyl, tetrahydronaphthyl, pyridyl, quinolyl or benzo[1,3]dioxol-5-yl, and R5 is H, alkyl or aminoalkyl. The compounds are used in the manufacture of medicaments for the treatment of disorders modulated by a peroxisome proliferator activated receptor.
Patent NZ-527578-A (NZ)
Title: Method and apparatus for media buying
Inventor: LEWIS STUART CHARLES
IPC: G06Q10/00
Filed: 2003-08-12
Abstract: A computer-implemented method for graphically displaying media buying options (4) includes determining two or three attributes of each media buying option with one of the attributes being an exposure attribute and displaying a plot (1) of available media buying options (4), wherein the media buying options (4) are plotted against a first axis (1B) corresponding to the exposure attribute and a second axis (1A) corresponding to the other or one of the other attributes. In response to the displayed media buying option being selected or deselected for purchase calculating the exposure attribute for each media buying options to account for the exposure of the selected or deselected media buying option and displaying the new plot of the media buying options including the recalculated exposure attributes.
Patent NZ-528954-A (NZ)
Title: Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors
Inventor: SURLERAUX DOMINIQUE LOUIS NEST
IPC: C07D493/04
Filed: 2002-04-09
Abstract: 2-(substituted-amino)-benzoxazole sulfonamides of formula (I), N-oxides, salts, stereoisomeric forms, racemic mixtures, prodrugs, esters and metabolites thereof are disclosed, wherein the variables shown in formula (I) are as defined in the specification. These compounds may be suitable for use as broadspectrum HIV protease inhibitors. Processes for the preparation of these compounds, as well as pharmaceutical compositions and diagnostic kits comprising them, and combinations thereof with another anti-retroviral agent, and their use in assays as reference compounds or as reagents are also disclosed.
Patent NZ-537105-A (NZ)
Title: A method of managing supplier/purchaser interfaces via internet or intranet
Inventor: CAMPBELL WAYNE J
Filed: 2004-12-09
Abstract: A supplier/purchaser system for managing one or more supplier/purchaser interfaces using an internet or intranet based computer system to enable sellers and buyers to trade on credit terms. Services are provided via an internet browser interface to allow suppliers to provide and update product information, purchasers to view products and place orders, a purchaser to be debited with at least a partial payment, and the supplier to be credited with the same at least partial payment. Also provided via an internet based interface is a database in which transactions are stored such that a debtors/creditors transaction ledger can be retrieved therefrom.
Patent NZ-537859-A (NZ)
Title: Methods of forming a nuclear transfer embyro by destabilizing microtubules of a non-human oocyte
Inventor: OVERSTROM ERIC W
IPC: C12N15/873
Filed: 2003-07-29
Abstract: A method of forming a nuclear transfer embryo by destabilizing microtubules of a non-human mammalian oocyte, whereby essentially all endogenous chromatin collects at the second polar body during meiosis of the oocyte. The oocyte is combined with the nucleus of a donor somatic cell of the same species of the non-human mammalian oocyte prior to cessation of extrusion of the second polar body from the oocyte and thus forming the nuclear transfer embryo. Also disclosed are methods of cloning a non-human mammal or fetus, producing a transgenic non-human mammal and producing a protein of interest.
Patent NZ-538289-A (NZ)
Title: Method of removing solid carbon dioxide from cryogenic equipment
Inventor: AMIN ROBERT
IPC: C01B32/55
Filed: 2003-08-27
Abstract: A method of removing solid carbon dioxide from cryogenic equipment is disclosed, wherein the method comprises the steps of: (a) introducing a stream including ethane to said cryogenic equipment to convert solid carbon dioxide to liquid form whereby a mixture of liquid ethane and liquid carbon dioxide is formed; and (b) removing the mixture of liquid ethane and carbon dioxide from the cryogenic equipment. In particular, the method can be used in a liquefied natural gas (LNG) plant wherein cryogenic equipment contains LNG, and the method comprises the steps of: (a') removing the LNG from the said cryogenic equipment; (a) introducing a stream including ethane to convert solid carbon dioxide to liquid form whereby a mixture of liquid ethane and liquid carbon dioxide is formed; and (b) removing the mixture of liquid ethane and liquid carbon dioxide from the cryogenic equipment. The result is an effective cleaning method for fouled LNG equipment.
Patent NZ-541998-A (NZ)
Title: Submersible netpen
Inventor: YTTERLAND ANDERS
IPC: A01K61/00
Filed: 2004-02-06
Abstract: A netpen 1 for breeding, storing and transporting fish in the sea and that can be semi-submersed or floated high in the water, is formed in the shape of a dual curved body such as a sphere or ellipsoid that is rotatable about a horizontal axis. The netpen includes a framework of stays 2, 3, 4 of polyethylene and a horizontal centre cylinder 5 extending through the pen. The centre cylinder is sufficiently stiff to serve as an attachment and supporting structure for the pen and as a buoyancy adjusting element for the pen by adjusting the amount of water within the cylinder.
Patent NZ-546274-A (NZ)
Title: Pyrazolopyridines and analags thereof
Inventor: HAYS DAVID S
IPC: A61K31/4745
Filed: 2004-10-01
Abstract: Pyrazolopyridin-4-amines, pyrazoloquinolin-4-amines, pyrazolonaphthyridin-4-amines, and 6,7,8,9-tetrahydropyrazoloquinolin-4-amines, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.
Patent NZ-547691-A (NZ)
Title: Concrete reclamation apparatus utilizing two connected containers, the first of which has a strainer
Inventor: CONNARD III LESLIE R
IPC: B28C5/42
Filed: 2005-01-10
Abstract: An apparatus 10 useful in the separation of solids from a diluted, wet, concrete mixture, such as wet concrete mixtures carried within the mixing drum of a concrete mixture delivery vehicle, the apparatus 10 comprising: (a) a free standing first container 16 having an internal volume of at least about one half gallon, the first container 16 having a drain port and a top opening; (b) a strainer disposed within the first container 16 so as to bifurcate the internal volume of the first container 16 into a first portion and a second portion, the second portion including the drain port of the first container 16, the strainer having a plurality of apertures; (c) a first container 16 drain port shut-off valve for alternatively opening and closing the drain port of the first container 16; (d) one or more connectors for attaching the first container 16 to the pour chute of a concrete mixture delivery vehicle; (e) a second container 20 separate from the mixing drum of the concrete mixture delivery vehicle, the second container 20 having an internal volume of at least about 5 gallons, the second container 20 being attached to the concrete mixture delivery vehicle and having an inlet port and a drain port; and (f) a transfer conduit 22 for connecting the drain port of the first container in fluid tight communication with the inlet port of the second container 20, so that liquid within the second portion of the first container 16 can be gravitated to the second container 20.
Patent NZ-547903-A (NZ)
Title: A method of generating an authentication token and a method of authenticating an online transaction
Inventor: DEWE CAROLINE MOSTYN
IPC: H04L9/32
Filed: 2006-06-14
Abstract: A method of generating an authentication token as disclosed. The method comprises the steps of: (i.) downloading a cryptographic based application to a mobile telephony device; (ii.) running the cryptographic based application on the mobile telephony device; and (iii.) displaying a token generated by the cryptographic based application on a display of the mobile telephony device.
Patent NZ-551625-A (NZ)
Title: T-cell death-inducing epitopes
Inventor: CHANG CHUNG NAN
IPC: A61K38/08
Filed: 2005-05-11
Abstract: Disclosed is an isolated polypeptide comprising X1-X2-X3-X4-X5, when used to identify a ligand. Binding of said ligand to said polypeptide on activated T-cells induces death of the cells, and X1 is Tyr, Trp, His, or Met; X2 is Asp; X3 is Ser, Phe, Pro, Glu, or His; X4 is any amino acid; and X5 is Pro, Tyr, His, or Trp Wherein said ligand is identified by contacting said ligand with said polypeptide wherein binding of said ligand to said polypeptide on activated T-cells induces death of the cells. Also disclosed is a method of producing an antibody that binds to the polypeptide and induces death of activated T-cells.
Patent NZ-553938-A (NZ)
Title: Photovoltaic cell
Inventor: STERZEL HANS-JOSEF
IPC: H01L31/0296
Filed: 2005-10-25
Abstract: Disclosed is a photovoltaic cell comprising a photovoltaically active semiconductor of the formula (Zn1-xMnxTe)1-y(SiaTeb)y, where x is from 0.01 to 0.99, y is from 0.01 to 0.2, a is from 1 to 2, and b is from 1 to 3, and a process for producing the photovoltaic cell.
Patent NZ-565081-A (NZ)
Title: Bag-in box
Inventor: INOUE KIMIHIRO
IPC: B65D77/06
Filed: 2006-06-08
Abstract: A bag-in-box includes an inner bag formed integrally with a liquid spout 40 detachably threaded with a cap 38 or a hose 42 and housed in an outer box 18 of an approximately rectangular parallelepiped shape. The box has four side plates 12C forming a body part, a top plate forming a double structure top part 14A, 14B, 14C, and 14D, and a bottom plate forming a double structure bottom part. An approximately U-shaped flap having a tip extending from a fold line 20 at a position spaced apart by a prescribed distance from an upper edge of a side plate 12C connected to a top plate positioned on the inside of the double structure towards the top plate, is folded inward about the fold line. A fixing hole 22 for fixedly fitting the liquid spout, and a slot 24 enabling insertion of the fingers of an operator, are formed in this order in the flap from the fold line toward the tip. Perforations enabling the tear-off of a portion facing the fixing hole and the slot are formed in a top plate positioned on the outside of the double structure.
Patent NZ-566781-A (NZ)
Title: Method of culturing thermophilic microorganisms suitable for the production of ethanol
Inventor: ATKINSON ANTHONY
IPC: C12R1/01
Filed: 2006-10-05
Abstract: Disclosed is a method for the production of thermophilic microorganisms suitable for the production of ethanol, comprising: i. culturing a thermophilic microorganism under aerobic or anaerobic conditions in a suitable culture media; and ii. incorporating amounts of ethanol into the culture media to induce ethanol tolerance; wherein the wild-type thermophilic microorganism is modified by inactivation of the native lactate dehydrogenase gene, and wherein the native lactate dehydrogenase gene, or a portion, thereof, has been deleted.
Patent NZ-569350-A (NZ)
Title: Mite composition comprising glycyphagidae and phytoseiid mites, use thereof, method for rearing a phytoseiid predatory mite, rearing system for rearing said phytoseiid predatory mite and methods for biological pest control on a crop
Inventor: BOLCKMANS KAREL JOZEF FLORENT
IPC: A01K67/00
Filed: 2005-12-29
Abstract: Provided is a mite composition comprising: - a rearing population of a phytoseiid predatory mite species, - a factitious host population, - and a carrier for individuals of said populations, wherein the factitious host population comprises at least one species selected from the family of the Glyciphagidae, with the proviso that the phytoseiid predatory mite species is selected from a species other than Amblyseius swirskii.
Patent NZ-572373-A (NZ)
Title: Methods for treating rheumatoid arthritis using a taci-ig fusion molecule
Inventor: BROLY HERVE
IPC: A61K33/242
Filed: 2007-05-15
Abstract: Use of a composition comprising a fusion molecule comprising: (a) TACT extracellular domain or fragment thereof which binds BlyS ; and (b) a human immunoglobulin-constant domain for the manufacture of a medicament for treating rheumatoid arthritis in a patient; wherein said medicament is formulated for administration of said composition in an amount of 0.01 mg per 1 kg of patient's body weight to 10 mg/kg body weight; and wherein said medicament, when administered is administered in said amount: (i) 7 times during a twelve-week interval; or (ii) 3 times during a four-week interval; or (iii) every other week for 2 to 30 weeks; or (iv) weekly; with the proviso that said medicament, when administered is not administered for 7 continuous days.
Patent NZ-574152-A (NZ)
Title: An adjustable bed having a mattress coupled to a portion of the bed base by way of a snap fit buckle
Inventor: BEARD ALLYN
IPC: A47C20/04
Filed: 2006-08-24
Abstract: An adjustable bed is disclosed. The adjustable bed comprises; (a) a bed base having a plurality of support panels defining a mattress support surface where at least one of the support panels is movable relative to at least one other support panel to adjust the bed; (b) a mattress located atop the support surface; and (c) a snap-fit buckle for securing the mattress atop the support surface. The buckle comprises a male and female element. One of the male and female elements is secured to the top of one of the support panels, and the other of the male and female elements are secured to an underside surface of the mattress. Engagement of the male and female elements of the buckles fixes the position of the mattress on one of the support panels.
Patent NZ-574663-A (NZ)
Title: Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders
Inventor: GRAZIANI EDMUND IDRIS
IPC: A61K31/436
Filed: 2005-12-15
Abstract: Rapamycin analogues of formula (I) are disclosed, wherein the variables are as defined in the specification. These compounds are useful in treating neurological disorders or complications due to stroke or head injury; benign or malignant neoplastic disease, carcinomas and adenocarcinomas; proliferative disorders; and inflammatory disorders. The compounds are therefore useful as neuroprotective and neurogenerative, anti-proliferative, and anti-inflammatory agents. (62) Divided Out of 556375
Patent NZ-576595-A (NZ)
Title: Composition comprising oligogalacturonans and polycationic saccharides
Inventor: VAN CUTSEM PIERRE
IPC: C08L5/06
Filed: 2007-11-28
Abstract: Disclosed herein is a composition comprising one or more oligogalacturonan(s) with a degree of polymerization comprised between 9 and 20 and having a dimeric egg box conformation further stabilized by one or more polycationic saccarides (s), such as a chitosan saccharide.